Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline

Shock

Volumn 9, Issue 1, 1998, Pages 12-20

  Kleinschmidt, Stefan ^a   Wanner, Guido A ^a   Bußmann, Dirk ^a   Kremer, Jean Pierre ^b   Ziegenfuß, Thomas ^a   Menger, Michael D ^a   Bauer, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE; PENTOXIFYLLINE;

ADULT; AGED; ARTICLE; BIOMETRY; BLOOD; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STIMULATION;

ADULT; AGED; BIOMETRY; CORONARY ARTERY BYPASS; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PENTOXIFYLLINE; PROSPECTIVE STUDIES; STIMULATION, CHEMICAL;

EID: 0031601755     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199801000-00002     Document Type: Article

References (36)

1. Butler J, Rocker M, Westaby S: Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 55:552-559, 1993.
2. Bastien O, Pirio V: The immune response to cardiopulmonary bypass. Curr Opin Anesthesiol 9:76-80, 1996.
3. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, et al: Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 54:744-748, 1992.
4. Steinberg JB, Kapelanski DP, Oison JD, et al: Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 106:1008-1016, 1993.
5. Livingston DH, Mosenthal AC, Deitch SA: Sepsis and multi organ dysfunction syndrome: A clinical-mechanistic overview. New Horiz 3:257-266, 1995.
6. Bauer M: Pathophysiologie der Sepsis-aktuelle Konzepte. (Pathophysiology of sepsis: Current concepts). Anaesthesist 45:312-322, 1996.
7. Ayala A, Ertel W, Chaudry IH: Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90, 1996.
8. Bone R: Sir Isaac Newton, sepsis, SIRS and CARS. Crit Care Med 24:1125-1128, 1996.
9. Deng MC, Wiedner M, Erren M, et al: Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 9:22-29, 1995.
10. Milar AB, Armstrong L, van der Linde J, et al: Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 56:1499-1502, 1993.
11. Seghaye M, Duchateau J, Bruniaux J, et al: Interleukin 10-release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 111:545-553, 1996.
12. Tabardel Y, Duchateau J, Schmartz D, et al: Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in man. Surgery 119:76-80, 1996.
13. Wang P, Ba Z, Zhou M, Morrison M, et al: Pentoxifylline restores cardiac output and tissue perfusion after trauma hemorrhage and decreases susceptibility to sepsis. Surgery 112:451-458, 1992.
14. Zabel P, Schade F, Schlaak M: Inhibition of endogenous TNF-α formation by pentoxifylline. Immunobiology 187:447-463, 1993.
15. Wilson BMG, Severn A, Rapson NT, et al: A convenient human whole blood culture system for studying the regulation of tumour necrosis factor release by bacterial lipopolysaccharide. J Immunol Methods 139:233-240, 1991.
16. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
17. Bauer M, Pannen B, Bauer I, et al: Evidence for a functional link between stress response and vascular control in hepatic portal circulation. Am J Physiol 271:(Gastrointest Liver Physiol 34):G929-G935, 1996.
18. Wanner GA, Ertel W, Müller P, et al: Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 5:34-40, 1996.
19. Espevik T, Nissen-Meyer J: A high sensitive cell-line, WEHI 164 clone 13, for measuring cytotoxic/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
20. 2-terminal amino acid sequence of a T-cell derived lymphokine growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83:9679-9683, 1986.
21. Anderson LW, Landow L, Baek L, et al: Association between gastric intramucosal pH and splanchnic endotoxin, antibody to endotoxin, and tumor necrosis factor-α concentrations in patients undergoing cardiopulmonary bypass. Crit Care Med 21:210-217, 1993.
22. Tao W, Zwischenberger JB, Nguyen TT, et al: Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand. J Thorac Cardiovasc Surg 110:819-828, 1995.
23. Martinez-Pellus AE, Merino P, Bru M, et al: Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 21:1684-1691, 1993.
24. Roumen RMH, Hendriks T, van-der-Ven-Jongekrijg J, et al: Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 218:769-776, 1993.
25. Girndt M, Köhler H, Schiedhelm-Weick E, et al: Production of interleukin-6, tumor necrosis factor a and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47:559-565, 1995.
26. Ertel W, Kremer JP, Kenney J, et al: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995.
27. Keel M, Schregenberger N, Steckholzer U, et al: Endotoxin tolerance after severe injury and its regulatory mechanisms. J Trauma 41:430-438, 1996.
28. Scatter SC, Li MH, Bubrick MP, et al: Endotoxin pretreatment of human monocytes alters subsequent endotoxin-triggered release of inflammatory mediators. Shock 3:252-258, 1995.
29. Ayala A, Deol ZK, Lehman DL, et al: Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch Surg 130:1178-1185, 1995.
30. deWaal Malefyt R, Abrams J, Bennett B, et al: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991.
31. Randow F, Syrbe U, Meisel CL, et al: Mechanisms of endotoxin desensitization: Involvement of IL-10 and TGFβ. J Exp Med 181:1878-1892, 1995.
32. Chernoff AE, Granowitz EV, Shapiro L, et al: A randomized, controlled trial of IL-10 in humans: Inhibition of inflammatory cytokine production and immune response. J Immunol 154:5492-5499, 1995.
33. Zabel P, Wolter D, Schönharting M, et al: Oxpentifylline in endotoxemia. Lancet 2:1474-1477, 1989.
34. Barsig J, Küsters S, Vogt K, et al: Lipopolysaccharide-induced interleukin-10 in mice: Role of endogenous tumor necrosis factor-a. Eur J Immunol 25:2888-2893, 1995.
35. Teofoli P, Lotti T: Cytokines, fibrinolysis, and vasculitis. Int Angiol 14:125-129, 1995.
36. Montravers P, Fagon JY, Gilbert C, et al: Pilot study of cardiopulmonary risk from pentoxifylline in adult respiratory distress syndrome. Chest 103:1017-1022, 1993.